As Keffola has mentioned, my understanding is a lot of the trials are supplied at cost, and the margins (30-60% as stated from the company) don't kick in until they sign off on the commercial deals.
Because of that, looking at the previous financial documents for any indication of margin is not going to be accurate. Due to the nature of the product though i believe the company that a margin of 30% is perfectly realistic.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.69M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1521039 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 3117282 | 3 |
View Market Depth
| Last trade - 16.21pm 04/07/2025 (20 minute delay) ? |
| AJX (ASX) Chart |
Day chart unavailable